A. Wallin

960 total citations
12 papers, 694 citations indexed

About

A. Wallin is a scholar working on Psychiatry and Mental health, Physiology and Geriatrics and Gerontology. According to data from OpenAlex, A. Wallin has authored 12 papers receiving a total of 694 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Psychiatry and Mental health, 6 papers in Physiology and 3 papers in Geriatrics and Gerontology. Recurrent topics in A. Wallin's work include Dementia and Cognitive Impairment Research (9 papers), Alzheimer's disease research and treatments (6 papers) and Frailty in Older Adults (2 papers). A. Wallin is often cited by papers focused on Dementia and Cognitive Impairment Research (9 papers), Alzheimer's disease research and treatments (6 papers) and Frailty in Older Adults (2 papers). A. Wallin collaborates with scholars based in Sweden, Italy and Norway. A. Wallin's co-authors include Lennart Minthon, Kaj Blennow, Elisabet Londos, Carina Wattmo, Magnus Sjögren, Oskar Hansson, Nancy C. Andreasen, Henrik Zetterberg, Kaj Blennow and Lars Rosengren and has published in prestigious journals such as Neurology, Journal of Neurology Neurosurgery & Psychiatry and The Gerontologist.

In The Last Decade

A. Wallin

12 papers receiving 676 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
A. Wallin Sweden 10 430 390 150 127 105 12 694
Hae Ri Na South Korea 18 272 0.6× 352 0.9× 98 0.7× 121 1.0× 70 0.7× 66 837
Hyun Jeong Han South Korea 16 211 0.5× 243 0.6× 56 0.4× 85 0.7× 73 0.7× 51 595
Virginia Pappas United States 4 444 1.0× 549 1.4× 85 0.6× 66 0.5× 55 0.5× 8 764
Luc Truyen United States 11 162 0.4× 323 0.8× 91 0.6× 78 0.6× 74 0.7× 16 782
Szofia Bullain United States 13 300 0.7× 386 1.0× 96 0.6× 99 0.8× 87 0.8× 32 749
Luiza Spiru Romania 7 428 1.0× 427 1.1× 88 0.6× 135 1.1× 50 0.5× 26 688
Federica Ribaldi Switzerland 14 384 0.9× 347 0.9× 163 1.1× 117 0.9× 46 0.4× 52 760
Shinji Sudoh Japan 12 321 0.7× 135 0.3× 128 0.9× 82 0.6× 80 0.8× 17 610
P. Tariska Hungary 4 152 0.4× 243 0.6× 58 0.4× 78 0.6× 46 0.4× 7 470
Guoqiao Wang United States 14 317 0.7× 231 0.6× 96 0.6× 60 0.5× 57 0.5× 43 700

Countries citing papers authored by A. Wallin

Since Specialization
Citations

This map shows the geographic impact of A. Wallin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. Wallin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. Wallin more than expected).

Fields of papers citing papers by A. Wallin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A. Wallin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. Wallin. The network helps show where A. Wallin may publish in the future.

Co-authorship network of co-authors of A. Wallin

This figure shows the co-authorship network connecting the top 25 collaborators of A. Wallin. A scholar is included among the top collaborators of A. Wallin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A. Wallin. A. Wallin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Parnetti, Lucilla, Davide Chiasserini, Ulf Andréasson, et al.. (2010). Changes in CSF acetyl- and butyrylcholinesterase activity after long-term treatment with AChE inhibitors in Alzheimer’s disease. Acta Neurologica Scandinavica. 124(2). 122–129. 32 indexed citations
2.
Wattmo, Carina, A. Wallin, Elisabet Londos, & Lennart Minthon. (2010). Risk Factors for Nursing Home Placement in Alzheimer's Disease: A Longitudinal Study of Cognition, ADL, Service Utilization, and Cholinesterase Inhibitor Treatment. The Gerontologist. 51(1). 17–27. 88 indexed citations
3.
Wallin, A., Kaj Blennow, Henrik Zetterberg, et al.. (2010). CSF biomarkers predict a more malignant outcome in Alzheimer disease. Neurology. 74(19). 1531–1537. 151 indexed citations
4.
Wallin, A., Oskar Hansson, Kaj Blennow, Elisabet Londos, & Lennart Minthon. (2009). Can CSF biomarkers or pre‐treatment progression rate predict response to cholinesterase inhibitor treatment in Alzheimer's disease?. International Journal of Geriatric Psychiatry. 24(6). 638–647. 28 indexed citations
5.
Minthon, Lennart, A. Wallin, S. Eriksson, Carina Wattmo, & Nancy C. Andreasen. (2008). Long-term rivastigmine treatment in a routine clinical setting. Acta Neurologica Scandinavica. 119(3). 180–185. 18 indexed citations
6.
Wallin, A., Kaj Blennow, Nancy C. Andreasen, & Lennart Minthon. (2006). CSF Biomarkers for Alzheimer’s Disease: Levels of β-Amyloid, Tau, Phosphorylated Tau Relate to Clinical Symptoms and Survival. Dementia and Geriatric Cognitive Disorders. 21(3). 131–138. 93 indexed citations
7.
Wallin, A., Lars Gustafson, Magnus Sjögren, Carina Wattmo, & Lennart Minthon. (2004). Five-Year Outcome of Cholinergic Treatment of Alzheimer’s Disease: Early Response Predicts Prolonged Time until Nursing Home Placement, but Does Not Alter Life Expectancy. Dementia and Geriatric Cognitive Disorders. 18(2). 197–206. 35 indexed citations
8.
Verhey, Frans R.J., Felicia A. Huppert, P.J. Houx, et al.. (2003). Cross-national comparisons of the Cambridge Cognitive Examination-revised: the CAMCOG-R: Results from the European Harmonization Project for Instruments in Dementia. Age and Ageing. 32(5). 534–540. 39 indexed citations
9.
Sjögren, Magnus, Lars Rosengren, Lennart Minthon, et al.. (2000). Cytoskeleton proteins in CSF distinguish frontotemporal dementia from AD. Neurology. 54(10). 1960–1964. 152 indexed citations
10.
Wallin, A.. (1996). Current definition and classification of dementia diseases. Acta Neurologica Scandinavica. 94. 39–44. 5 indexed citations
11.
Landén, Mikael, Annika Thorsell, A. Wallin, & Kaj Blennow. (1996). The apolipoprotein E allele epsilon 4 does not correlate with the number of senile plaques or neurofibrillary tangles in patients with Alzheimer's disease.. Journal of Neurology Neurosurgery & Psychiatry. 61(4). 352–356. 48 indexed citations
12.
Eriksson, Britt‐Marie & A. Wallin. (1995). Evaluation of the liquid-chromatographic resolution of indenoindolic racemic compounds on three protein-based chiral stationary phases. Journal of Pharmaceutical and Biomedical Analysis. 13(4-5). 551–561. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hae Ri Na Breakdown of academic impact, for papers by Hyun Jeong Han Breakdown of academic impact, for papers by Virginia Pappas Breakdown of academic impact, for papers by Luc Truyen Breakdown of academic impact, for papers by Szofia Bullain Breakdown of academic impact, for papers by Luiza Spiru Breakdown of academic impact, for papers by Federica Ribaldi Breakdown of academic impact, for papers by Shinji Sudoh Breakdown of academic impact, for papers by P. Tariska Breakdown of academic impact, for papers by Guoqiao Wang
Rankless by CCL
2026